Development of a liposomal nanodelivery system for nevirapine

BACKGROUND: The treatment of AIDS remains a serious challenge owing to high genetic variation of Human Immunodeficiency Virus type 1 (HIV-1). The use of different antiretroviral drugs (ARV) is significantly limited by severe side-effects that further compromise the quality of life of the AIDS patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramana, Lakshmi N, Sethuraman, Swaminathan, Ranga, Udaykumar, Krishnan, Uma M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914021/
https://www.ncbi.nlm.nih.gov/pubmed/20624325
http://dx.doi.org/10.1186/1423-0127-17-57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914021/
https://www.ncbi.nlm.nih.gov/pubmed/20624325
http://dx.doi.org/10.1186/1423-0127-17-57

Ejemplares similares